| abstract |
Provided herein are recombinant glycoproteins (e. G., Recombinant human alpha -galactosidase-A protein) with altered (e.g., improved) glycosylation profile, and pharmaceuticals comprising one or more of such proteins Compositions and kits. Also provided are methods of producing mammalian cells useful for recombinant expression of glycoproteins (e. G., Recombinant human alpha -galactosidase-A), methods of making recombinant glycoproteins, and recombinant glycoproteins Recombinant human [alpha] -galactosidase-A protein) to a subject. |